Clinical Trial: Comparative Analysis of the Efficacy and Safety of Nafamostat Mesylate and Unfractionated Heparin for Anticoagulation during Extracorporeal Membrane Oxygenation (China)

China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Comparative Analysis of the Efficacy and Safety of Nafamostat Mesylate and Unfractionated Heparin for Anticoagulation during Extracorporeal Membrane Oxygenation'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131277

Registration Time: 2026/08/31

Type: Observational study

Primary Sponsor: Northern Jiangsu People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=335342

Published by HT Digital Content Services with permission from Health Daily Digest....